"Graft vs Host Disease" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION.
| Descriptor ID |
D006086
|
| MeSH Number(s) |
C20.452
|
| Concept/Terms |
Graft vs Host Disease- Graft vs Host Disease
- Graft-Versus-Host Disease
- Disease, Graft-Versus-Host
- Diseases, Graft-Versus-Host
- Graft Versus Host Disease
- Graft-Versus-Host Diseases
- Runt Disease
- Disease, Runt
- Graft-vs-Host Disease
- Disease, Graft-vs-Host
- Diseases, Graft-vs-Host
- Graft-vs-Host Diseases
- Homologous Wasting Disease
- Disease, Homologous Wasting
|
Below are MeSH descriptors whose meaning is more general than "Graft vs Host Disease".
Below are MeSH descriptors whose meaning is more specific than "Graft vs Host Disease".
This graph shows the total number of publications written about "Graft vs Host Disease" by people in this website by year, and whether "Graft vs Host Disease" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 2 | 2 |
| 1997 | 1 | 1 | 2 |
| 1999 | 0 | 2 | 2 |
| 2000 | 1 | 1 | 2 |
| 2001 | 3 | 2 | 5 |
| 2002 | 5 | 3 | 8 |
| 2003 | 7 | 5 | 12 |
| 2004 | 5 | 1 | 6 |
| 2005 | 5 | 4 | 9 |
| 2006 | 5 | 3 | 8 |
| 2007 | 4 | 4 | 8 |
| 2008 | 9 | 6 | 15 |
| 2009 | 6 | 4 | 10 |
| 2010 | 12 | 4 | 16 |
| 2011 | 12 | 6 | 18 |
| 2012 | 13 | 3 | 16 |
| 2013 | 10 | 4 | 14 |
| 2014 | 17 | 8 | 25 |
| 2015 | 20 | 11 | 31 |
| 2016 | 12 | 9 | 21 |
| 2017 | 14 | 5 | 19 |
| 2018 | 20 | 9 | 29 |
| 2019 | 22 | 7 | 29 |
| 2020 | 28 | 3 | 31 |
| 2021 | 20 | 6 | 26 |
| 2022 | 25 | 0 | 25 |
| 2023 | 29 | 1 | 30 |
| 2024 | 17 | 6 | 23 |
| 2025 | 8 | 5 | 13 |
| 2026 | 6 | 2 | 8 |
To return to the timeline,
click here.
Below are the most recent publications written about "Graft vs Host Disease" by people in Profiles.
-
Early administration of calcineurin inhibitors limits the tolerogenic effect of PTCy in allogeneic hematopoietic transplant. Blood. 2026 Nov 05; 148(19):2423-2435.
-
Graft-versus-host disease prophylaxis shapes T cell biology and immune reconstitution after hematopoietic cell transplant. Sci Transl Med. 2026 Oct 21; 18(872):eaef7406.
-
Phase II Study of Posttransplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis After HLA-Mismatched Unrelated Donor Reduced Intensity Transplantation: Results From the ACCESS Trial Expansion Cohort. Am J Hematol. 2026 Nov; 101(11):2827-2835.
-
Toward Standardized Screening for Chronic Graft-Versus-Host Disease: Insights from the Engraft Learning Network. Transplant Cell Ther. 2026 Oct; 32(10):1303.e1-1303.e12.
-
CAR19 Tregs treat murine chronic graft-versus-host disease through immune suppression without measurable B cell cytolysis. JCI Insight. 2026 08 24; 11(16).
-
Third-Party Viral Specific T Cells for Immunocompromised Hosts and Access Barriers: A Review and Commentary by an Expert Panel from ASTCT. Transplant Cell Ther. 2026 Sep; 32(9):1051.e1-1051.e10.
-
MHC class I on target cells regulates CD4+ T cell-mediated immunity. Nat Immunol. 2026 May; 27(5):1000-1012.
-
Fecal carbohydrate-degrading bacteria are associated with reduced incidence of lower gastrointestinal GVHD. Blood Adv. 2026 Mar 24; 10(6):1979-1991.
-
Cognitive Functioning in Vorinostat-Treated Pediatric and Young Adult Patients Over the First 180 Days After Hematopoietic Stem Cell Transplant. Pediatr Blood Cancer. 2026 Jun; 73(6):e70259.
-
Optimizing Haploidentical Donor Selection for Pediatric Hematopoietic Cell Transplant. J Clin Oncol. 2026 Apr 10; 44(11):1003-1015.